BioCryst Pharmaceuticals ($BCRX) Insider Trading & Smart Money Activity
BioCryst Pharmaceuticals, Inc. ($BCRX) has 6 insider trades, 1 congress trade, 7 13F position changes and 2 analyst ratings on file. Insiders filed 6 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 1
- 13F moves on file
- 7
- Analyst ratings on file
- 2
BCRX insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 1 |
| Q2 2026 | 0 | 0 | 0 / 0 | 3 / 3 |
| Q3 2026 | 0 | 0 | 1 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All BCRX insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Congress | Gilbert Ray Cisneros Jr. | Purchase | $1,001 - $15,000 | -11.1% | -5.8% | — | |||||
| Analyst | HC Wainwright | Reiterates to buy | PT $32 | +9.9% | -7.6% | Read | |||||
| Analyst | Cantor Fitzgerald | Reiterates to buy | PT $29 | +9.9% | -7.6% | Read | |||||
| Insider | Jon Stonehouse | Buy (Grant or award) | 33.54K sh | +5.8% | +16.6% | — | |||||
| Insider | Machelle Sanders | Buy (Grant or award) | 15.29K sh | +5.8% | +16.6% | — | |||||
| Insider | Vincent Milano | Buy (Grant or award) | 33.54K sh | +5.8% | +16.6% | — | |||||
| Insider | Amy Mckee | Buy (Grant or award) | 33.54K sh | +5.8% | +16.6% | — | |||||
| Insider | Theresa Heggie | Buy (Grant or award) | 15.29K sh | +5.8% | +16.6% | — | |||||
| Insider | Steven Frank | Buy (Grant or award) | 33.54K sh | +5.8% | +16.6% | — | |||||
| 13F | Two Sigma Advisers | Sold out | -4.09M sh | -8.1% | +0.4% | — | |||||
| 13F | Two Sigma Advisers | Sold out | -4.09M sh | -8.1% | +0.4% | — | |||||
| 13F | Schonfeld Strategic Advisors | Added | +1.20M sh | $13.38M | -8.1% | +0.4% | Read | ||||
| 13F | Baker Bros. Advisors | Sold out | -2.82M sh | -8.1% | +0.4% | — | |||||
| 13F | Imc-Chicago | New | +631.29K sh | $6.31M | -2.5% | -6.2% | — | ||||
| 13F | Imc-Chicago | New | +631.29K sh | $5.37M | -2.5% | -6.2% | — | ||||
| 13F | Avoro Capital Advisors | Sold out | -1.25M sh | +9.5% | +41.2% | +39.6% | Read |
1W / 1M / 6M = how BCRX moved from the trade or filing date.
Insider trading in BCRX: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Jon Stonehouse | 1 | — | Jun 11, 2026 | ||
| Machelle Sanders | 1 | — | Jun 11, 2026 | ||
| Vincent Milano | 1 | — | Jun 11, 2026 | ||
| Amy Mckee | 1 | — | Jun 11, 2026 | ||
| Theresa Heggie | 1 | — | Jun 11, 2026 | ||
| Steven Frank | 1 | — | Jun 11, 2026 |
Members of Congress trading BCRX
Institutions moving BCRX (13F)
Analyst ratings on BCRX
Frequently asked questions
What is the latest insider trade in BCRX?
Jon Stonehouse filed a buy (grant or award) of 33.54K sh on Jun 11, 2026.
Which members of Congress traded BCRX?
1 disclosed trade by Gilbert Ray Cisneros Jr.. The latest was on Jul 10, 2026.
Which institutions changed their BCRX positions?
Recent 13F filers moving the stock include Two Sigma Advisers, Imc-Chicago, Schonfeld Strategic Advisors, Baker Bros. Advisors and Avoro Capital Advisors.
Other drug manufacturers - specialty & generic stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.